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Abstract
The National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides breast 
and cervical cancer screening and diagnostic services to low-income, uninsured, and underinsured 
women across the nation. Although the program has provided services to more than 5 million 
women since 1991, there remains a significant burden of breast and cervical cancer with inequities 
among certain populations. To reduce this burden and improve health equity, the NBCCEDP is 
expanding its scope to include population-based strategies to increase screening in health systems 
and communities through the implementation of patient and provider evidence-based 
interventions, connecting women in communities to clinical services, increasing opportunities to 
access screening, and enhancing the targeting of women in need of services. The goal is to reach 
more women and make sure women are getting the right screening test at the right time.
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Introduction
CANCER IS A MAJOR cause of death and disability in the United States. Breast cancer is 
the most commonly diagnosed cancer and the second leading cause of cancer deaths among 
women across the United States.1 Although the incidence of, and mortality due to, cervical 
cancer has decreased over the past five decades, it still remains a significant burden to some 
groups of women.1 To reduce breast and cervical cancer burden, the U.S. Preventive 
Services Task Force (USPSTF) recommends routine screening for both these cancers for 
women of certain ages.2,3 The goal of screening is to find invasive cancer or premalignant 
lesions early, when treatment is most effective or invasive cancer can be prevented. However, 
access to screening and treatment is not equally attained by all women, especially those who 
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are uninsured, with a low income level, or have disabilities.4,5 To reduce breast and cervical 
cancer mortality among low-income women who do not have access to medical services, 
Congress created the National Breast and Cervical Cancer Early Detection Program 
(NBCCEDP) through the Breast and Cervical Cancer Mortality Prevention Act of 1990.6
The NBCCEDP is managed by the Centers for Disease Control and Prevention (CDC) and 
began screening women through funded state health departments in 1991. Currently the 
program funds all the 50 states, the District of Columbia, 13 tribes/tribal organizations, and 
6 U.S. territories.7 This program is the only nationwide organized breast and cervical cancer 
screening program in the United States, serving more than 5 million women over its 27 years 
of existence. Along with a national infrastructure of awardee-established screening provider 
networks, the NBCCEDP monitors program activities to assure provision of quality services 
and timely follow-up.
Program Activities
Historically, the emphasis of the NBCCEDP has been to provide direct breast and cervical 
cancer screening and diagnostic services for low-income uninsured and under-insured 
women as authorized in the Breast and Cervical Cancer Mortality Prevention Act of 1990.6 
Health departments (or their bona fide agents) receive funding from the CDC and contract 
with health care delivery systems in their communities to provide a broad range of clinical 
services. Women diagnosed with cancer or premalignant lesions may be referred for 
treatment to the state’s Medicaid program under the Breast and Cervical Cancer Prevention 
and Treatment Act of 2000 (BCCPTA)8 and the Native American Breast and Cervical 
Cancer Treatment Technical Amendment Act of 2001.9 Throughout the screening and 
diagnostic process, women are offered patient navigation services to assist with overcoming 
barriers that may interfere with accessing and completing appropriate screening and 
diagnostic care.
In addition, the NBCCEDP has a comprehensive approach to increasing cancer screening by 
providing other supportive activities.10,11 Public education and outreach help to increase 
awareness and motivate women to get screened. Professional development keeps providers 
updated on evidence-based clinical standards regarding breast and cervical cancer screening 
and diagnostic pathways. Quality assurance and quality improvement processes ensure that 
women receive appropriate clinical testing and follow-up. Together, these activities 
maximize the quality of care that women receive.
To implement an organized national screening approach, CDC established program policies, 
including eligibility and reimbursement criteria for the program.12 Low income is defined as 
family income at or below 250% of the federal poverty level. The target eligibility age is 
women 40–64 years for breast cancer and 21–64 years for cervical cancer, consistent with 
the age for screening recommendations. Women ages 65 and older are typically eligible for 
screening under Medicare. However, any woman age 65 and older who does not qualify for 
Medicare or who cannot afford Medicare Part B premium is eligible to receive NBCCEDP 
services. In an effort to direct clinical services to women who are most at-risk, the program 
prioritizes women ages 50–64 years for breast cancer screening and women who are rarely 
or never screened for cervical cancer screening.12
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Since 1991, the NBCCEDP has served more than 5 million women; provided more than 12 
million breast and cervical cancer screening examinations; and found nearly 65,000 invasive 
breast cancers, 4500 invasive cervical cancers, 21,000 premalignant breast lesions, and 
204,000 premalignant cervical lesions.7 Program evaluation is essential for guiding program 
planning, development, and implementation. CDC has placed a high priority on evaluating 
the effectiveness of the NBCCEDP and used the findings to continuously make program 
improvements.
The NBCCEDP collects clinical data on each patient encounter to monitor the services 
provided and ensure accountability relative to appropriate services and timely follow-up. 
CDC supports the extensive data management requirements of awardees to maintain data 
quality.13 Standardized data are reported to CDC biannually that describe the demographic 
characteristics and clinical outcomes of the women served. Summary feedback reports of the 
analyzed clinical data are subsequently shared with each awardee for use. These data are 
used for program management, ongoing quality assurance/quality improvement, program 
planning, and program evaluation. These data have also been instrumental in helping to 
shape program policy development at CDC and in Congress. For example, data on the time 
delays and efforts required by the NBCCEDP awardees to secure pro-bono treatment for 
uninsured women diagnosed with cancer informed Congress ’ decision to pass the BCCPTA.
14
While the NBCCEDP has served many women, this is only a small percentage of the women 
eligible for the program. Using the U.S. Census Bureau’s Current Population Survey and the 
NBCCEDP’s data for 2010–2012, there were 9.8 million low-income women in the United 
States who were eligible for NBCCEDP cervical cancer services. However, only 6.5% of 
eligible women were served by the program, while 60.2% of eligible women were screened 
for cervical cancer outside the program.15 As for breast cancer screening, data from 2011 to 
2012 identified ~5.2 million low-income women eligible for the NBCCEDP, with 10.6% 
served by the program and 30.6% screened outside the program.16 A study by Ku et al. 
assessing the potential impact of the Affordable Care Act projected that the uninsured rate 
among women eligible for the NBCCEDP would decrease significantly, but ~5.7 million 
low-income women would remain uninsured by 2017.17 These data indicate that there were 
still women not being screened and that CDC could consider other options to increase the 
cancer screening rates for low-income women.
New Program Activities
In 2016, CDC began to explore untapped opportunities to reach more women in need of 
screening for breast and cervical cancer, especially low-income women. Following the 
model set by CDC’s Colorectal Cancer Control Program (CRCCP),18 strategies to increase 
clinic-level screening rates were incorporated into the new NBCCEDP funding opportunity.
19
 Hence, the NBCCEDP awardees now partner with clinics that serve low-income women 
and help implement evidence-based interventions (EBIs) known to be effective in increasing 
breast and cervical cancer screening. In 2015, CRCCP began to focus directly on 
implementing EBIs recommended by the Guide to Community Preventive Services20 as 
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effective in increasing colorectal cancer screening in clinics. A 4.4 percentage point increase 
in clinic-level screening rates was achieved in the first program year.18 These promising 
findings offer a model for the NBCCEDP to expand its reach and help more women get 
screened for breast and cervical cancer through collaboration with health systems and clinics 
to effectively utilize EBIs such as patient and provider reminders, provider screening 
performance feedback reports, and interventions to reduce structural barriers.20
Other new areas of emphasis include community/clinical linkages and environmental 
approaches. For community/clinical linkages, awardees work with community organizations 
to connect disadvantaged women who need screening to appropriate cancer screening 
services at partner health clinics in their community. For environmental approaches, 
awardees collaborate with employers and other organizations to implement worksite policies 
that help women gain access to and support the completion of screening. The NBCCEDP 
logic model (Fig. 1) outlines awardees’ strategies and activities supported by CDC funding 
along with the expected short-term, intermediate-term, and long-term outcomes.
In addition, complementary activities such as the development of well-designed small 
media, delivery of continuing education for providers and health system partners, and 
improvement in the use of electronic health records are supported. Increasing the use of data 
to better target interventions and allocate limited resources is another important activity. 
Data are used to identify disparate populations (e.g., low income, uninsured, high cancer 
incidence and death rates, low screening rates) and geographic areas (e.g., states, counties, 
cities) in greater need of screening. Data help inform which interventions are needed and 
appropriate, and how resources can be allocated to improve health equity. Multiple other 
data sources with state- and substate (e.g., county, city)-level information are available to 
NBCCEDP directors to help inform their planning.21–23
Public Health Implications
With an eye farther into the future, the NBCCEDP is a critical public health program in 
helping women getting the right breast and cervical cancer screening test at the right time. 
CDC’s strengths in data, translation, evaluation, and partnerships could help facilitate 
progress toward achieving this goal. Specifically, the NBCCEDP is working toward 
improving cancer screening across the United States and identifying best practices that work 
in different settings and among different populations for scaling and replication in other 
settings across the country.19
In expanding the NBCCEDP’s scope, it is important to clearly communicate the evolution of 
the program to embrace underutilized opportunities to increase cancer screening rates on a 
population level; and to encourage the support and participation of stakeholders who are 
essential partners in making health systems’ and clinic-based interventions successful and 
sustainable. To address this communication priority, CDC has developed a new visual brand 
for CDC’s cancer screening programs in partnership with the National Association of 
Chronic Disease Directors–ScreenOutCancer: Advancing Cancer Prevention Nationwide.24 
The ultimate goal communicated by the brand is simple and clear—to “Screen. Out. 
Cancer.” The tagline, “Advancing Cancer Prevention Nationwide,” brings together the 
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efforts of CDC and its awardees across the United States to collectively achieve a common 
goal.
Across the nation, the NBCCEDP has nearly three decades of public health experience, 
leadership, and data, plus established cancer screening infrastructures and partnerships, to 
build on and share with health systems and other new partners as awardees pursue 
population-based approaches to increase cancer screening rates. Addressing inequities in 
breast and cervical cancer and fully utilizing available data to target geographic areas and 
populations with high disease burden and low screening rates will continue to be important.
25,26
 Awardees can work with providers and clinics that serve a high proportion of low-
income populations in need of screening; these include community health centers, safety net 
hospitals, rural health clinics that serve geographically isolated communities, and urban and 
minority health clinics located in low-income neighborhoods that serve a diverse 
populations.
In summary, the NBCCEDP has embarked on new strategies to raise population-level cancer 
screening rates while continuing to meet its central purpose to serve at-risk women by 
providing them with direct screening services for breast and cervical cancer. We have 
strategically mapped out forward-thinking goals and core strategies, and are applying our 
nearly three decades of expertise, experience, and established infrastructure to maximize the 
likelihood of success in the future while we build new expertise and capacity in 
collaborating with health systems.19 The NBCCEDP is working to reach more women, 
especially among populations that have high disease burden and persistent low screening 
rates. CDC awardees can put successful processes into practice across the nation to increase 
breast and cervical cancer screening rates.
Acknowledgments
The NBCCEDP is currently supported by the CDC cooperative agreement DP17–1701. The findings and 
conclusions in this article are those of the authors and do not necessarily represent the official position of the 
Centers for Disease Control and Prevention.
References
1. U.S. Cancer Statistics Working Group. U.S. Cancer Statistics Data Visualizations Tool, based on 
November 2017 submission data (1999–2015): U.S. Department of Health and Human Services, 
Centers for Disease Control and Prevention and National Cancer Institute Available at: 
www.cdc.gov/cancer/dataviz Accessed January 9, 2019.
2. Final Update Summary: Breast Cancer: Screening. U.S. Preventive Services Task Force 2 2018 
Available at: www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/breast-
cancer-screening1. Accessed January 8, 2019.
3. Final Update Summary: Cervical Cancer: Screening. U.S. Preventive Services Task Force 8 2018 
Available at: www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/
cervical-cancer-screening2 Accessed January 8, 2019.
4. Steele CB, Townsend JS, Courtney-Long EA, Young M. Cancer screening prevalence among adults 
with disabilities, United States, 2013. Prev Chronic Dis 2017;14:160312.
5. White A, Thompson TD, White MC, et al. Cancer screening test use—United States, 2015. MMWR 
Morb Mortal Wkly Rep 2017;66:201–206. [PubMed: 28253225] 
6. Breast and Cervical Cancer Mortality Prevention Act of 1990. Pub L 301–354. Available at: http://
uscode.http://uscode.house.gov/statutes/pl/101/354.pdf Accessed December 28, 2018.
Wong and Miller Page 5





















7. CDC. National Breast and Cervical Cancer Early Detection Program: About the program. Available 
at: www.cdc.gov/cancer/nbccedp/about.htm Accessed December 28, 2018.
8. Breast and Cervical Cancer Prevention and Treatment Act of 2000. Pub L 106–354. Available at: 
www.cdc.gov/cancer/nbccedp/pdf/publ354–106.pdf Accessed December 28, 2018.
9. Native American Breast and Cervical Cancer Treatment Technical Act of 2001. Available at: 
www.govinfo.gov/content/pkg/BILLS-107s1741enr/pdf/BILLS-107s1741enr.pdf Accessed January 
9, 2019.
10. Miller JW, Plescia M, Ekwueme DU. Public Health National Approach to reducing breast and 
cervical cancer disparities. Cancer 2014;120 Suppl 16:2537–2539. [PubMed: 25099895] 
11. CDC. National Breast and Cervical Cancer Early Detection Program: The NBCCEDP conceptual 
framework. Available at: www.cdc.gov/cancer/nbccedp/concept.htm Accessed December 28, 
2018.
12. Lee NC, Wong FL, Jamison PM, et al. Implementation of the National Breast and Cervical Cancer 
Early Detection Program: The beginning. Cancer 2014;120 Suppl 16:2540–2548. [PubMed: 
25099896] 
13. Yancy B, Royalty JE, Marroulis S, Mattingly C, Benard VB, DeGroff A. Using data to effectively 
manage a national screening program. Cancer 2014;120 Suppl 16:2575–2583. [PubMed: 
25099900] 
14. Lantz PM, Weisman CS, Itani Z. A disease-specific Medicaid expansion for women: The Breast 
and Cervical Cancer Prevention and Treatment Act of 2000. Womens Health Issues 2003;13:79–
92. [PubMed: 12867087] 
15. Tangka FK, Howard DH, Royalty J, et al. Cervical cancer screening of underserved women in the 
United States: Results from the National Breast and Cervical Cancer Early Detection Program, 
1997–2012. Cancer Causes Control 2015;26:671–686. [PubMed: 25783455] 
16. Howard DH, Tangka FK, Royalty J, et al. Breast cancer screening of underserved women in the 
USA: Results from the National Breast and Cervical Cancer Early Detection Program, 1998–2012. 
Cancer Causes Control 2015;26:657–658. [PubMed: 25779379] 
17. Ku L, Bysshe T, Steinmetz E, Bruen BK. Health reform, Medicaid expansions, and women’s 
cancer screening. Womens Health Issues 2016;26:256–261. [PubMed: 26926159] 
18. DeGroff A, Sharma K, Satsangi A, et al. Increasing colorectal cancer screening in health care 
systems using evidence-based interventions. Prev Chronic Dis 2018;15:180029.
19. CDC. Cancer Prevention and Control Programs for State, Territorial, and Tribal Organizations. 
Available at: www.grants.gov/web/grants/search-grants.html?keywords=dp17-1701 Accessed 
January 9, 2019.
20. Community Preventive Services Task Force. The Guide to Community Preventive Services. 
Available at: www.thecommunityguide.org Accessed January 8, 2019.
21. CDC. Behavioral Risk Factor Surveillance System. Available at: www.cdc.gov/brfss Accessed 
January 9, 2019.
22. Berkowitz Z, Zhang X, Richards TB, et al. Multilevel regression for small-area estimation of 
mammography use in the United States, 2014. Cancer Epidemiol Biomarkers Prev 2019;28:32–40. 
[PubMed: 30275116] 
23. Berkowitz Z, Zhang X, Richards TB, et al. Multilevel small-area estimation of colorectal cancer 
screening in the United States. Cancer Epidemiol Biomarkers Prev 2018;27: 245–253. [PubMed: 
29500250] 
24. CDC. Screen Out Cancer. Available at: www.cdc.gov/screenoutcancer/index.htm Accessed 
December 28, 2018.
25. Miller JW, Lee Smith J, Ryerson AB, et al. Disparities in breast cancer survival in the United States 
(2001–2009): Findings from the CONCORD-2 study. Cancer 2017;123 Suppl 24:5100–5118. 
[PubMed: 29205311] 
26. Benard V, Watson M, Saraiya M, et al. Cervical cancer survival in the United States by race and 
stage (2001–2009): Findings from the CONCORD-2 study. Cancer 2017;123 Suppl 24:5119–
5137. [PubMed: 29205300] 
Wong and Miller Page 6






















National Breast and Cervical Cancer Early Detection Program logic model. NCCCP, 
National Comprehensive Cancer Control Program; NPCR, National Program of Cancer 
Registries; MDE, minimum data elements; EBI, evidence-based interventions; CDC, 
Centers for Disease Control and Prevention.
Wong and Miller Page 7
J Womens Health (Larchmt). Author manuscript; available in PMC 2020 April 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
